Cherry Biotech

Cherry Biotech is a biomedical technology (Organ on Chip) company that develops instruments for drug discovery and personalised medicine. Its mission is to replace animal testing by reconstructing human tissue (Organoids) in vitro for drug testing. Cherry Biotechs CUBIX platform enables pharmaceutical, biotech companies and healthcare providers to recreate immunocompetent human vascularized organ models and tumor microenvironments for better evaluation of their drug candidates. By enabling the reconstruction of human 3D models that mimic human physiology and pathophysiology over several weeks, Cherry Biotechs proprietary CUBIX technology is the only solution that can convert a standard 2D multi-well plate into a...

Biotechnology,diabetes type 2,in vitro,microphysiological system,pharmaceutical,research,organ on a chip,liver on a chip,drug development,toxicology,preclinical phase,microenvironment controller,animal testing alternative,precision medicine,3d cell culture,3d in vitro cro,and contract research organization (cro)

Cherry biotech operates in the Biotechnology research industry.

Cherry biotech's revenue is 11m - 100m

Cherry biotech has 11 - 50 employees.